<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
 <head>
  <title>Discharged on Statin Medication</title>
  <style type="text/css"> 
 body { 
 color: rgb(26, 26, 26); 
 background-color: rgb(255,255,255); 
 font-family: Verdana, Tahoma, sans-serif; 
 font-size: 11px; 
 } 
 a { 
 color: rgb(0, 0, 255); 
 background-color: rgb(255,255,255); 
 } 
 h1 { 
 font-size: 12pt; 
 font-weight: bold; 
 } 
 h2 { 
 font-size: 11pt; 
 font-weight: bold; 
 } 
 h3 { 
 font-size: 10pt; 
 font-weight: bold; 
 } 
 h4 { 
 font-size: 8pt; 
 font-weight: bold; 
 } 
 div { 
 width: 80%; 
 } 
 table { 
 line-height: 10pt; 
 width: 80%; 
 font-size: 11px; 
 } 
 .inner_table { 
 width: 100%; 
 } 
 .inner_table td {
border-color:#ffffff;
border-style:solid;
border-width:1px;
border-top: 0;
border-left: 0;
border-right: 0;
}
.inner_table tbody > tr:last-child > td  {
border-bottom-style:none;
}
.ver { 
 padding: 0px 5px} 
 tr { 
 background-color: rgb(224,224,224); 
 } 
 td { 
 padding: 0.1cm 0.2cm; 
 vertical-align: top; 
 } 
 .h1center { 
 font-size: 12pt; 
 font-weight: bold; 
 text-align: center; 
 width: 80%;} 
 .header_table{ 
 border: 1pt inset rgb(0,0,0);} 
 .narr_table { 
 width: 100%; 
 } 
 .narr_tr { 
 background-color: rgb(225,225,225); 
 } 
 pre { 
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */ 
 white-space: pre-wrap; /* css-3 */ 
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */ 
 white-space: -pre-wrap; /* Opera 4-6 */ 
 white-space: -o-pre-wrap; /* Opera 7 */ 
 word-wrap: break-word; /* Internet Explorer 5.5+ */ 
 font-family: Verdana, Tahoma, sans-serif; 
 font-size: 11px; 
 text-align:left; 
 margin: 0px 0px 0px 0px; 
 padding:0px 0px 0px 0px; 
 } 
 .narr_th { 
 background-color: rgb(201,201,201); 
 } 
 .td_label{ 
 font-weight: bold; 
 color: white; 
 }</style>
 </head>
 <body>
  <table class="header_table">
   <tbody>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">eMeasure Title</span></td>
     <td style="width:80%" colspan="3"><h1 style="font-size:10px">Discharged on Statin Medication</h1></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">eMeasure Identifier (Measure Authoring Tool)</span></td>
     <td style="width:30%">105</td>
     <td style="background-color:#656565; width:20%"><span class="td_label">eMeasure Version number</span></td>
     <td style="width:30%">6.1.000</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">NQF Number</span></td>
     <td style="width:30%">Not Applicable</td>
     <td style="background-color:#656565; width:20%"><span class="td_label">GUID</span></td>
     <td>1f503318-bb8d-4b91-af63-223ae0a2328e</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measurement Period</span></td>
     <td style="width:80%" colspan="3">January 1, 20XX through December 31, 20XX</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Steward</span></td>
     <td style="width:80%" colspan="3">The Joint Commission</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Developer</span></td>
     <td style="width:80%" colspan="3">The Joint Commission</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Endorsed By</span></td>
     <td style="width:80%" colspan="3">None</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Description</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Ischemic stroke patients who are prescribed or continuing to take statin medication at hospital discharge</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Copyright</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Measure specifications are in the Public Domain.

LOINC(R) is a registered trademark of the Regenstrief Institute.

This material contains SNOMED Clinical Terms (R) (SNOMED CT[C]) copyright 2004-2016 International Health Terminology Standards Development Organization. All rights reserved.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Disclaimer</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Scoring</span></td>
     <td style="width:80%" colspan="3">Proportion</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Type</span></td>
     <td style="width:80%" colspan="3">Process</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Item Count</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Encounter, Performed: Non-Elective Inpatient Encounter</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Stratification</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>None</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Risk Adjustment</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>None</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Rate Aggregation</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>None</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Rationale</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>There is an extensive and consistent body of evidence supporting the use of statins for secondary prevention in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD), which includes individuals with ischemic stroke due to large artery atherosclerosis, individuals with ischemic stroke due to intrinsic small vessel disease, and individuals with ischemic stroke not directly due to atherosclerosis but with clinically evident atherosclerotic disease in an uninvolved cerebral or noncerebral bed.  Both women and men with clinical ASCVD are at increased risk for recurrent ASCVD and ASCVD death.  High-intensity statin therapy should be initiated or continued as first-line therapy in women and men less than or equal to 75 years of age who have clinical ASCVD, unless contraindicated. In patients with clinical ASCVD and a contraindication to high-intensity statin therapy, moderate-intensity therapy should be considered as an alternative if it can be tolerated.  In individuals greater than 75 years of age, the potential for ASCVD risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences should be considered, and statin therapy individualized based on these considerations (Stone, 2013).</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Clinical Recommendation Statement</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>For patients with stroke of atherosclerotic origin, intensive lipid lowering therapy with statins should be initiated</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Improvement Notation</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Improvement noted as an increase in rate</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Stone NJ, Robinson J, Lichtenstein AH, Noel Bairey Merz C, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero Jr, ST, Smith SC, Watson K, Wilson PWF. &quot;Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.&quot; [In eng]. Circulation 11, (Nov 2013): 1-84. </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Amarenco, P., J. Bogousslavsky, A. Callahan, 3rd, L. B. Goldstein, M. Hennerici, A. E. Rudolph, H. Sillesen, et al. &quot;High-Dose Atorvastatin after Stroke or Transient Ischemic Attack.&quot; [In eng]. N Engl J Med 355, no. 6 (Aug 10 2006): 549-59</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Feher, A., G. Pusch, K. Koltai, A. Tibold, B. Gasztonyi, L. Szapary, and G. Feher. &quot;Statintherapy in the Primary and the Secondary Prevention of Ischaemic Cerebrovascular Diseases.&quot; [In eng]. Int J Cardiol 148, no. 2 (Apr 14 2011): 131-8.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Kernan, W.N., B. Ovbiagele, H. R. Black, D. M. Bravata, M. I. Chimowitz, M. D. Ezekowitz, M. C. Fang, M. Fisher, K. L. Furie, D. V. Heck, S. C. Johnston, S. E. Kasner, S. J. Kittner, P. H. Mitchell, M. W. Rich, D. Richardson, L. H. Schwamm, J. A. Wilson. &quot;Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association.&quot; [in eng.]  Stroke 45, no. 7 (May 2014): 2160-223</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Adults Treatment of High Blood Cholesterol in Adults.&quot;Third Report of the National Cholesterol Education Program (Ncep) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Iii) Final Report.&quot; [In eng]. Circulation 106, no. 25 (Dec 17 2002): 3143-421.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Squizzato, A., E. Romualdi, F. Dentali, and W. Ageno. &quot;Statins for Acute Ischemic Stroke.&quot; [In eng]. Cochrane Database Syst Rev, no. 8 (2011): CD007551.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Definition</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>None</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Guidance</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>The &quot;Non-elective Inpatient Encounter&quot; value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the &quot;Inpatient encounter&quot; value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions.

The &quot;Medication, Discharge&quot; datatype refers to the discharge medication list and is intended to express medications ordered for post-discharge use.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Transmission Format</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>TBD</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Initial Population</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patients age 18 and older discharged from inpatient care (non-elective admissions) with a principal diagnosis of ischemic or hemorrhagic stroke and a length of stay less than or equal to 120 days that ends during measurement period</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patients with a principal diagnosis of ischemic stroke</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator Exclusions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>*Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.
*Patients with comfort measures documented
*Patients discharged to another hospital
*Patients who left against medical advice
*Patients who expired
*Patients discharged to home for hospice care
*Patients discharged to a health care facility for hospice care
*Patients with an LDL-c of less than 70 mg/dL &lt;30 days prior to arrival or any time during the hospital stay</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Numerator</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patients prescribed or continuing to take statin medication at hospital discharge</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Numerator Exclusions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Not Applicable</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator Exceptions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patients with a reason for not prescribing statin medication at discharge</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Supplemental Data Elements</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>For every patient evaluated by this measure also identify payer, race, ethnicity and sex</pre>
      </div></td>
    </tr>
   </tbody>
  </table>
  <h2><a name="toc">Table of Contents</a></h2>
  <ul>
   <li><a href="#d1e405">Population Criteria</a></li>
   <li><a href="#d1e539">Data Criteria (QDM Variables)</a></li>
   <li><a href="#d1e647">Data Criteria (QDM Data Elements)</a></li>
   <li><a href="#d1e767">Supplemental Data Elements</a></li>
   <li><a href="#d1e879">Risk Adjustment Variables</a></li>
  </ul>
  <div style="float:left; background:teal; height:3px; width:80%"></div>
  <pre><br /></pre>
  <h3><a name="d1e405" href="#toc">Population Criteria</a></h3>
  <div>
   <ul>
    <li><b>Initial Population =</b>
     <ul>
      <li> AND: Age&gt;= 18 year(s) at: Occurrence A of $EncounterInpatientNonElective </li>
      <li>AND:
       <ul>
        <li>OR: Intersection of: 
         <ul>
          <li>Occurrence A of $EncounterInpatientNonElective </li>
          <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter (principal diagnosis: Ischemic Stroke)&quot; </li>
         </ul></li>
        <li>OR: Intersection of: 
         <ul>
          <li>Occurrence A of $EncounterInpatientNonElective </li>
          <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter (principal diagnosis: Hemorrhagic Stroke)&quot; </li>
         </ul></li>
       </ul></li>
     </ul></li>
    <li><b>Denominator =</b>
     <ul>
      <li>AND: Initial Population</li>
     </ul>
     <ul>
      <li>AND: Intersection of: 
       <ul>
        <li>Occurrence A of $EncounterInpatientNonElective </li>
        <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter (principal diagnosis: Ischemic Stroke)&quot; </li>
       </ul></li>
     </ul></li>
    <li><b>Denominator Exclusions =</b>
     <ul>
      <li> OR: &quot;Laboratory Test, Performed: LDL-c&quot;  satisfies all:
       <ul>
        <li> (result &lt; 70 mg/dL) </li>
        <li> satisfies any:
         <ul>
          <li>&lt;= 30 day(s) ends before start of Occurrence A of $EncounterInpatientNonElective </li>
          <li>starts during Occurrence A of $EncounterInpatientNonElective </li>
         </ul></li>
       </ul></li>
      <li>OR: Intersection of: 
       <ul>
        <li>Occurrence A of $EncounterInpatientNonElective </li>
        <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter&quot;  satisfies any:
         <ul>
          <li> (discharge status: Discharge To Acute Care Facility) </li>
          <li> (discharge status: Left Against Medical Advice) </li>
          <li> (discharge status: Patient Expired) </li>
          <li> (discharge status: Discharged to Home for Hospice Care) </li>
          <li> (discharge status: Discharged to Health Care Facility for Hospice Care) </li>
         </ul></li>
       </ul></li>
      <li>OR: $InterventionComfortMeasures starts during  (&quot;Encounter, Performed: Emergency Department Visit&quot; &lt;= 1 hour(s) ends before or concurrent with start of Occurrence A of $EncounterInpatientNonElective ) </li>
      <li>OR: $InterventionComfortMeasures starts during Occurrence A of $EncounterInpatientNonElective </li>
     </ul></li>
    <li><b>Numerator =</b>
     <ul>
      <li>AND: &quot;Medication, Discharge: Statin Grouper&quot; starts during Occurrence A of $EncounterInpatientNonElective </li>
     </ul></li>
    <li><b>Numerator Exclusions =</b>
     <ul>
      <li>None</li>
     </ul></li>
    <li><b>Denominator Exceptions =</b>
     <ul>
      <li>OR: &quot;Medication, Allergy: Statin Allergen&quot; starts before or concurrent with end of Occurrence A of $EncounterInpatientNonElective </li>
      <li>OR: Union of: 
       <ul>
        <li>&quot;Medication, Discharge not done: Patient Refusal&quot; for &quot;Statin Grouper&quot; </li>
        <li>&quot;Medication, Discharge not done: Medical Reason&quot; for &quot;Statin Grouper&quot; </li>
        <li>starts during Occurrence A of $EncounterInpatientNonElective </li>
       </ul></li>
     </ul></li>
    <li><b>Stratification =</b>
     <ul>
      <li>None</li>
     </ul></li>
   </ul>
  </div>
  <h3><a name="d1e539" href="#toc">Data Criteria (QDM Variables)</a></h3>
  <div>
   <ul>
    <li><b>$EncounterInpatientNonElective = </b>
     <ul>
      <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter&quot;  satisfies all:
       <ul>
        <li> (length of stay &lt;= 120 day(s)) </li>
        <li>ends during &quot;Measurement Period&quot; </li>
       </ul></li>
     </ul></li>
    <li><b>$InterventionComfortMeasures = </b>
     <ul>
      <li>Union of: 
       <ul>
        <li>&quot;Intervention, Order: Comfort Measures&quot; </li>
        <li>&quot;Intervention, Performed: Comfort Measures&quot; </li>
       </ul></li>
     </ul></li>
   </ul>
  </div>
  <h3><a name="d1e647" href="#toc">Data Criteria (QDM Data Elements)</a></h3>
  <div>
   <ul>
    <li>&quot;Encounter, Performed: Emergency Department Visit&quot; using &quot;Emergency Department Visit SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.292)&quot;</li>
    <li>&quot;Encounter, Performed: Non-Elective Inpatient Encounter&quot; using &quot;Non-Elective Inpatient Encounter SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.424)&quot;</li>
    <li>&quot;Intervention, Order: Comfort Measures&quot; using &quot;Comfort Measures SNOMEDCT Value Set (1.3.6.1.4.1.33895.1.3.0.45)&quot;</li>
    <li>&quot;Intervention, Performed: Comfort Measures&quot; using &quot;Comfort Measures SNOMEDCT Value Set (1.3.6.1.4.1.33895.1.3.0.45)&quot;</li>
    <li>&quot;Laboratory Test, Performed: LDL-c&quot; using &quot;LDL-c LOINC Value Set (2.16.840.1.113883.3.117.1.7.1.215)&quot;</li>
    <li>&quot;Medication, Allergy: Statin Allergen&quot; using &quot;Statin Allergen RXNORM Value Set (2.16.840.1.113883.3.117.1.7.1.423)&quot;</li>
    <li>&quot;Medication, Discharge: Statin Grouper&quot; using &quot;Statin Grouper Grouping Value Set (2.16.840.1.113762.1.4.1110.19)&quot;</li>
    <li>&quot;Medication, Discharge not done: Patient Refusal&quot; using &quot;Patient Refusal SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.93)&quot;</li>
    <li>&quot;Medication, Discharge not done: Medical Reason&quot; using &quot;Medical Reason SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.473)&quot;</li>
    <li> Attribute: &quot;Discharge status: Patient Expired&quot; using &quot;Patient Expired SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.309)&quot;</li>
    <li> Attribute: &quot;Discharge status: Left Against Medical Advice&quot; using &quot;Left Against Medical Advice SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.308)&quot;</li>
    <li> Attribute: &quot;Discharge status: Discharged to Health Care Facility for Hospice Care&quot; using &quot;Discharged to Health Care Facility for Hospice Care SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.207)&quot;</li>
    <li> Attribute: &quot;Principal diagnosis: Ischemic Stroke&quot; using &quot;Ischemic Stroke Grouping Value Set (2.16.840.1.113883.3.117.1.7.1.247)&quot;</li>
    <li> Attribute: &quot;Discharge status: Discharge To Acute Care Facility&quot; using &quot;Discharge To Acute Care Facility SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.87)&quot;</li>
    <li> Attribute: &quot;Discharge status: Discharged to Home for Hospice Care&quot; using &quot;Discharged to Home for Hospice Care SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.209)&quot;</li>
    <li> Attribute: &quot;Principal diagnosis: Hemorrhagic Stroke&quot; using &quot;Hemorrhagic Stroke Grouping Value Set (2.16.840.1.113883.3.117.1.7.1.212)&quot;</li>
   </ul>
  </div>
  <h3><a name="d1e767" href="#toc">Supplemental Data Elements</a></h3>
  <div>
   <ul>
    <li>&quot;Patient Characteristic Ethnicity: Ethnicity&quot; using &quot;Ethnicity CDCREC Value Set (2.16.840.1.114222.4.11.837)&quot;</li>
    <li>&quot;Patient Characteristic Payer: Payer&quot; using &quot;Payer SOP Value Set (2.16.840.1.114222.4.11.3591)&quot;</li>
    <li>&quot;Patient Characteristic Race: Race&quot; using &quot;Race CDCREC Value Set (2.16.840.1.114222.4.11.836)&quot;</li>
    <li>&quot;Patient Characteristic Sex: ONC Administrative Sex&quot; using &quot;ONC Administrative Sex AdministrativeGender Value Set (2.16.840.1.113762.1.4.1)&quot;</li>
   </ul>
  </div>
  <h3><a name="d1e879" href="#toc">Risk Adjustment Variables</a></h3>
  <div>
   <ul>
    <li>None</li>
   </ul>
  </div>
  <div style="float:left; background:teal; height:3px; width:80%"></div>
  <pre><br /></pre>
  <table class="header_table">
   <tbody>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Set</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>eMeasure Stroke (eSTK)</pre>
      </div></td>
    </tr>
   </tbody>
  </table>
 </body>
</html>